Key Events This Week
1 June: Mojo Grade upgraded from Strong Sell to Sell on improved financial and valuation metrics
2 June: Valuation grade shifted to Very Attractive amid sector challenges
5 June: Stock closes the week at Rs.35.24, up 3.22% on the day
Monday, 1 June: Upgrade to Sell Rating Sparks Early Optimism
Gujarat Terce Laboratories began the week on a positive note, closing at Rs.35.06, up 0.86% from the previous Friday’s close of Rs.34.76. This rise came despite the Sensex falling 0.96% to 35,077.62. The upgrade of the company’s mojo grade from Strong Sell to Sell by MarketsMOJO was a key catalyst. The rating change reflected improved financial trends, notably a sharp rise in profitability with a six-month PAT of ₹1.09 crore, and a more attractive valuation profile. However, the company’s net sales declined by 5.8% in the latest quarter, tempering enthusiasm.
Tuesday, 2 June: Valuation Shift to Very Attractive Amid Sector Challenges
On 2 June, the stock retreated 1.60% to Rs.34.50, underperforming the Sensex which gained 0.43%. This dip followed the announcement of a significant valuation upgrade, with Gujarat Terce Laboratories moving from a very expensive to a very attractive valuation grade. The stock’s price-to-earnings ratio stood at a modest 11.17, substantially lower than sector peers trading above 30. Other valuation metrics such as EV/EBITDA at 6.49 and a PEG ratio of 0.03 underscored the stock’s relative undervaluation. Despite the short-term price decline, these fundamentals suggested a compelling value proposition within the Pharmaceuticals & Biotechnology sector.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Wednesday, 3 June: Recovery Amid Market Weakness
The stock rebounded 1.10% to Rs.34.88 on 3 June, outperforming the Sensex which declined 0.34%. This recovery coincided with increased trading volume of 8,495 shares, the highest for the week, suggesting renewed investor interest. The mixed technical indicators, including a mildly bullish weekly MACD, may have contributed to this positive momentum. Nonetheless, the stock remained below its 52-week high of Rs.60.01, reflecting ongoing market caution.
Thursday, 4 June: Profit Taking and Volume Drought
On 4 June, Gujarat Terce Laboratories fell 2.12% to Rs.34.14, underperforming the Sensex which gained 0.19%. The decline was accompanied by a sharp drop in volume to just 408 shares, indicating limited trading interest. This price action may reflect profit taking after the prior day’s gains and the mixed technical outlook, with monthly indicators remaining bearish. The stock’s proximity to its 52-week low of Rs.29.00 continued to weigh on sentiment.
Friday, 5 June: Strong Finish with 3.22% Gain
The week closed on a strong note as the stock surged 3.22% to Rs.35.24, outperforming the Sensex which declined 0.10%. The uptick was supported by a volume increase to 3,860 shares, signalling renewed buying interest. This final day gain helped the stock post a weekly advance of 1.38%, contrasting with the Sensex’s 0.78% decline. The improved financial metrics, attractive valuation, and modest technical recovery likely underpinned this positive finish.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-01 | Rs.35.06 | +0.86% | 35,077.62 | -0.96% |
| 2026-06-02 | Rs.34.50 | -1.60% | 35,227.64 | +0.43% |
| 2026-06-03 | Rs.34.88 | +1.10% | 35,107.33 | -0.34% |
| 2026-06-04 | Rs.34.14 | -2.12% | 35,175.61 | +0.19% |
| 2026-06-05 | Rs.35.24 | +3.22% | 35,141.95 | -0.10% |
Key Takeaways
Improved Financial and Valuation Metrics: The upgrade from Strong Sell to Sell was driven by a notable rise in profitability and a shift to very attractive valuation metrics, including a low P/E of 11.17 and EV/EBITDA of 6.49. These factors suggest the stock is undervalued relative to its sector peers.
Mixed Price Performance and Technical Signals: The stock showed volatility during the week, with gains on Monday, Wednesday, and Friday offset by declines on Tuesday and Thursday. Technical indicators remain mixed, with weekly signals mildly bullish but monthly trends still bearish, indicating cautious optimism.
Volume Patterns Reflect Investor Sentiment: Trading volumes peaked midweek on 3 June, coinciding with a price recovery, but dipped sharply on 4 June, signalling profit taking and uncertainty. The volume rebound on Friday supported the strong finish.
Sector Challenges and Market Position: Despite sector headwinds and recent sales contraction, Gujarat Terce Laboratories’ operational efficiency and long-term returns remain strong. The stock trades near its 52-week low, highlighting the valuation reset and potential stabilisation phase.
Why settle for Gujarat Terce Laboratories Ltd? SwitchER evaluates this micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Conclusion
The week for Gujarat Terce Laboratories Ltd was characterised by a cautious but positive shift in market perception. The upgrade in mojo grade to Sell and the transition to a very attractive valuation grade reflect improved financial health and a more compelling price-to-value alignment. While the stock’s price movements were volatile and technical indicators remain mixed, the overall outperformance relative to the Sensex and strong operational metrics provide a foundation for stabilisation. Investors should continue to monitor upcoming financial results and sector developments to gauge whether this micro-cap can sustain its recovery amid ongoing challenges.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
